Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information
Issue
Vol. 29. Issue 2.
(March - April 2024)
Editorial board
Ann Hepatol. 2024;29:101483
Full text access
Editorial
The importance of fundamental pharmacology in fighting liver diseases
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Pablo Muriel
Ann Hepatol. 2024;29:101286
Full text access
A practical approach to the endoscopic management of biliary strictures after liver transplantation
Alex Bofill, Andrés Cárdenas
Ann Hepatol. 2024;29:101186
Full text access
Concise reviews
A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease
Maria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield
Ann Hepatol. 2024;29:101278
Full text access
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care
Inah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
Full text access
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, Varenka J Barbero-Becerra
Ann Hepatol. 2024;29:101182
Full text access
Original articles
The landscape of inpatient admissions for alcoholic hepatitis in the era of early liver transplantation
Shahana Prakash, Tomohiro Tanaka
Ann Hepatol. 2024;29:101169
Full text access
TCD assessment in fulminant hepatic failure: Improvements in cerebral autoregulation after liver transplantation
Fernando M Paschoal-Jr, Ricardo C Nogueira, Karla de Almeida Lins Ronconi, Marcelo de Lima Oliveira, Kelson James Almeida, Ivana Schmidtbauer Rocha, Eric Homero Albuquerque Paschoal, Joelma Karin Sagica Fernandes Paschoal, ... Edson Bor-Seng-Shu
Ann Hepatol. 2024;29:101167
Full text access
Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality
Hui Han, Qingtao Yu, Nina Qin, Bin Song, Yan Meng, Zuojing Feng, Zhaoping Li, Liyong Chen
Ann Hepatol. 2024;29:101177
Full text access
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Shudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
Full text access
Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic
Ann Hepatol. 2024;29:101184
Full text access
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT
Jeremy Lee, Christopher J. Byrne, Paul N. Brennan, Iain MacPherson, Eleanor Dow, John F. Dillon
Ann Hepatol. 2024;29:101280
Full text access
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
Full text access
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
Shuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, ... Yu He
Ann Hepatol. 2024;29:101279
Full text access
Brief report
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans
Siyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z. Mattos, Marco Arrese, Enrique Carrera, ... Andre Boonstra
Ann Hepatol. 2024;29:101181
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos